Global Biopharmaceuticals Market Size, Status and Forecast 2022

A biopharmaceutical, also known as a biologic (al) medical product, biological, or biologic, is any pharmaceutical drug product manufactured in, extracted from, or semi synthesized from biological sources. Different from totally synthesized pharmaceuticals, they include vaccines, blood, blood components, allergenic, somatic cells, gene therapies, tissues, recombinant therapeutic protein, and living cells used in cell therapy. Biologics can be composed of sugars, proteins, or nucleic acids or complex combinations of these substances, or may be living cells or tissues. They (or their precursors or components) are isolated from living sources—human, animal, plant, fungal, or microbial.

Market Analysis and Insights: Global Biopharmaceuticals Market

The global Biopharmaceuticals market size is projected to reach US$ 51410 million by 2027, from US$ 29900 million in 2020, at a CAGR of 8.0% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Biopharmaceuticals market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Biopharmaceuticals market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Biopharmaceuticals market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Biopharmaceuticals market.

Global Biopharmaceuticals Scope and Market Size

Biopharmaceuticals market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Biopharmaceuticals market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Monoclonal Antibodies

Interferon

Colony-Stimulating Factor

Erythropoietin

Insulin

Vaccines

Growth Hormones

Others

Tumor

Diabetes

Cardiovascular

Hemophilia

Others

North America

U.S.

Canada

Europe

Germany

France

U.K.

Italy

Russia

Nordic

Rest of Europe

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

Roche

Amgen

AbbVie

Sanofi-Aventis

Johnson & Johnson

Pfizer

Novo Nordisk

Eli Lilly

Novartis

Merck

Sun

3sbio

Changchun High Tech

CP Guojian

Biotech

Gelgen

Innovent

Dong Bao

Ganlee

United Laboratories

SANDOZ (NOVARTIS)

Teva Pharmaceutical

Hospira （Pfizer）

MYLAN

Sun pharma

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Biopharmaceuticals Market Size Growth Rate by Type: 2016 VS 2021 VS 2027

1.2.2 Monoclonal Antibodies

1.2.3 Interferon

1.2.4 Colony-Stimulating Factor

1.2.5 Erythropoietin

1.2.6 Insulin

1.2.7 Vaccines

1.2.8 Growth Hormones

1.2.9 Others

1.3 Market by Application

1.3.1 Global Biopharmaceuticals Market Share by Application: 2016 VS 2021 VS 2027

1.3.2 Tumor

1.3.3 Diabetes

1.3.4 Cardiovascular

1.3.5 Hemophilia

1.3.6 Others

1.4 Study Objectives

1.5 Years Considered

2.1 Global Biopharmaceuticals Market Perspective (2016-2027)

2.2 Biopharmaceuticals Growth Trends by Regions

2.2.1 Biopharmaceuticals Market Size by Regions: 2016 VS 2021 VS 2027

2.2.2 Biopharmaceuticals Historic Market Share by Regions (2016-2021)

2.2.3 Biopharmaceuticals Forecasted Market Size by Regions (2022-2027)

2.3 Biopharmaceuticals Industry Dynamic

2.3.1 Biopharmaceuticals Market Trends

2.3.2 Biopharmaceuticals Market Drivers

2.3.3 Biopharmaceuticals Market Challenges

2.3.4 Biopharmaceuticals Market Restraints

3.1 Global Top Biopharmaceuticals Players by Revenue

3.1.1 Global Top Biopharmaceuticals Players by Revenue (2016-2021)

3.1.2 Global Biopharmaceuticals Revenue Market Share by Players (2016-2021)

3.2 Global Biopharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

3.3 Players Covered: Ranking by Biopharmaceuticals Revenue

3.4 Global Biopharmaceuticals Market Concentration Ratio

3.4.1 Global Biopharmaceuticals Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Biopharmaceuticals Revenue in 2020

3.5 Biopharmaceuticals Key Players Head office and Area Served

3.6 Key Players Biopharmaceuticals Product Solution and Service

3.7 Date of Enter into Biopharmaceuticals Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Biopharmaceuticals Historic Market Size by Type (2016-2021)

4.2 Global Biopharmaceuticals Forecasted Market Size by Type (2022-2027)

5.1 Global Biopharmaceuticals Historic Market Size by Application (2016-2021)

5.2 Global Biopharmaceuticals Forecasted Market Size by Application (2022-2027)

6.1 North America Biopharmaceuticals Market Size (2016-2027)

6.2 North America Biopharmaceuticals Market Size by Type

6.2.1 North America Biopharmaceuticals Market Size by Type (2016-2021)

6.2.2 North America Biopharmaceuticals Market Size by Type (2022-2027)

6.2.3 North America Biopharmaceuticals Market Size by Type (2016-2027)

6.3 North America Biopharmaceuticals Market Size by Application

6.3.1 North America Biopharmaceuticals Market Size by Application (2016-2021)

6.3.2 North America Biopharmaceuticals Market Size by Application (2022-2027)

6.3.3 North America Biopharmaceuticals Market Size by Application (2016-2027)

6.4 North America Biopharmaceuticals Market Size by Country

6.4.1 North America Biopharmaceuticals Market Size by Country (2016-2021)

6.4.2 North America Biopharmaceuticals Market Size by Country (2022-2027)

6.4.3 United States

6.4.4 Canada

7.1 Europe Biopharmaceuticals Market Size (2016-2027)

7.2 Europe Biopharmaceuticals Market Size by Type

7.2.1 Europe Biopharmaceuticals Market Size by Type (2016-2021)

7.2.2 Europe Biopharmaceuticals Market Size by Type (2022-2027)

7.2.3 Europe Biopharmaceuticals Market Size by Type (2016-2027)

7.3 Europe Biopharmaceuticals Market Size by Application

7.3.1 Europe Biopharmaceuticals Market Size by Application (2016-2021)

7.3.2 Europe Biopharmaceuticals Market Size by Application (2022-2027)

7.3.3 Europe Biopharmaceuticals Market Size by Application (2016-2027)

7.4 Europe Biopharmaceuticals Market Size by Country

7.4.1 Europe Biopharmaceuticals Market Size by Country (2016-2021)

7.4.2 Europe Biopharmaceuticals Market Size by Country (2022-2027)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic

8.1 Asia-Pacific Biopharmaceuticals Market Size (2016-2027)

8.2 Asia-Pacific Biopharmaceuticals Market Size by Type

8.2.1 Asia-Pacific Biopharmaceuticals Market Size by Type (2016-2021)

8.2.2 Asia-Pacific Biopharmaceuticals Market Size by Type (2022-2027)

8.2.3 Asia-Pacific Biopharmaceuticals Market Size by Type (2016-2027)

8.3 Asia-Pacific Biopharmaceuticals Market Size by Application

8.3.1 Asia-Pacific Biopharmaceuticals Market Size by Application (2016-2021)

8.3.2 Asia-Pacific Biopharmaceuticals Market Size by Application (2022-2027)

8.3.3 Asia-Pacific Biopharmaceuticals Market Size by Application (2016-2027)

8.4 Asia-Pacific Biopharmaceuticals Market Size by Region

8.4.1 Asia-Pacific Biopharmaceuticals Market Size by Region (2016-2021)

8.4.2 Asia-Pacific Biopharmaceuticals Market Size by Region (2022-2027)

8.4.3 China

8.4.4 Japan

8.4.5 South Korea

8.4.6 Southeast Asia

8.4.7 India

8.4.8 Australia

9.1 Latin America Biopharmaceuticals Market Size (2016-2027)

9.2 Latin America Biopharmaceuticals Market Size by Type

9.2.1 Latin America Biopharmaceuticals Market Size by Type (2016-2021)

9.2.2 Latin America Biopharmaceuticals Market Size by Type (2022-2027)

9.2.3 Latin America Biopharmaceuticals Market Size by Type (2016-2027)

9.3 Latin America Biopharmaceuticals Market Size by Application

9.3.1 Latin America Biopharmaceuticals Market Size by Application (2016-2021)

9.3.2 Latin America Biopharmaceuticals Market Size by Application (2022-2027)

9.3.3 Latin America Biopharmaceuticals Market Size by Application (2016-2027)

9.4 Latin America Biopharmaceuticals Market Size by Country

9.4.1 Latin America Biopharmaceuticals Market Size by Country (2016-2021)

9.4.2 Latin America Biopharmaceuticals Market Size by Country (2022-2027)

9.4.3 Mexico

9.4.4 Brazil

10.1 Middle East & Africa Biopharmaceuticals Market Size (2016-2027)

10.2 Middle East & Africa Biopharmaceuticals Market Size by Type

10.2.1 Middle East & Africa Biopharmaceuticals Market Size by Type (2016-2021)

10.2.2 Middle East & Africa Biopharmaceuticals Market Size by Type (2022-2027)

10.2.3 Middle East & Africa Biopharmaceuticals Market Size by Type (2016-2027)

10.3 Middle East & Africa Biopharmaceuticals Market Size by Application

10.3.1 Middle East & Africa Biopharmaceuticals Market Size by Application (2016-2021)

10.3.2 Middle East & Africa Biopharmaceuticals Market Size by Application (2022-2027)

10.3.3 Middle East & Africa Biopharmaceuticals Market Size by Application (2016-2027)

10.4 Middle East & Africa Biopharmaceuticals Market Size by Country

10.4.1 Middle East & Africa Biopharmaceuticals Market Size by Country (2016-2021)

10.4.2 Middle East & Africa Biopharmaceuticals Market Size by Country (2022-2027)

10.4.3 Turkey

10.4.4 Saudi Arabia

10.4.5 UAE

11.1 Roche

11.1.1 Roche Company Details

11.1.2 Roche Business Overview

11.1.3 Roche Biopharmaceuticals Introduction

11.1.4 Roche Revenue in Biopharmaceuticals Business (2016-2021)

11.1.5 Roche Recent Development

11.2 Amgen

11.2.1 Amgen Company Details

11.2.2 Amgen Business Overview

11.2.3 Amgen Biopharmaceuticals Introduction

11.2.4 Amgen Revenue in Biopharmaceuticals Business (2016-2021)

11.2.5 Amgen Recent Development

11.3 AbbVie

11.3.1 AbbVie Company Details

11.3.2 AbbVie Business Overview

11.3.3 AbbVie Biopharmaceuticals Introduction

11.3.4 AbbVie Revenue in Biopharmaceuticals Business (2016-2021)

11.3.5 AbbVie Recent Development

11.4 Sanofi-Aventis

11.4.1 Sanofi-Aventis Company Details

11.4.2 Sanofi-Aventis Business Overview

11.4.3 Sanofi-Aventis Biopharmaceuticals Introduction

11.4.4 Sanofi-Aventis Revenue in Biopharmaceuticals Business (2016-2021)

11.4.5 Sanofi-Aventis Recent Development

11.5 Johnson & Johnson

11.5.1 Johnson & Johnson Company Details

11.5.2 Johnson & Johnson Business Overview

11.5.3 Johnson & Johnson Biopharmaceuticals Introduction

11.5.4 Johnson & Johnson Revenue in Biopharmaceuticals Business (2016-2021)

11.5.5 Johnson & Johnson Recent Development

11.6 Pfizer

11.6.1 Pfizer Company Details

11.6.2 Pfizer Business Overview

11.6.3 Pfizer Biopharmaceuticals Introduction

11.6.4 Pfizer Revenue in Biopharmaceuticals Business (2016-2021)

11.6.5 Pfizer Recent Development

11.7 Novo Nordisk

11.7.1 Novo Nordisk Company Details

11.7.2 Novo Nordisk Business Overview

11.7.3 Novo Nordisk Biopharmaceuticals Introduction

11.7.4 Novo Nordisk Revenue in Biopharmaceuticals Business (2016-2021)

11.7.5 Novo Nordisk Recent Development

11.8 Eli Lilly

11.8.1 Eli Lilly Company Details

11.8.2 Eli Lilly Business Overview

11.8.3 Eli Lilly Biopharmaceuticals Introduction

11.8.4 Eli Lilly Revenue in Biopharmaceuticals Business (2016-2021)

11.8.5 Eli Lilly Recent Development

11.9 Novartis

11.9.1 Novartis Company Details

11.9.2 Novartis Business Overview

11.9.3 Novartis Biopharmaceuticals Introduction

11.9.4 Novartis Revenue in Biopharmaceuticals Business (2016-2021)

11.9.5 Novartis Recent Development

11.10 Merck

11.10.1 Merck Company Details

11.10.2 Merck Business Overview

11.10.3 Merck Biopharmaceuticals Introduction

11.10.4 Merck Revenue in Biopharmaceuticals Business (2016-2021)

11.10.5 Merck Recent Development

11.11 Sun

11.11.1 Sun Company Details

11.11.2 Sun Business Overview

11.11.3 Sun Biopharmaceuticals Introduction

11.11.4 Sun Revenue in Biopharmaceuticals Business (2016-2021)

11.11.5 Sun Recent Development

11.12 3sbio

11.12.1 3sbio Company Details

11.12.2 3sbio Business Overview

11.12.3 3sbio Biopharmaceuticals Introduction

11.12.4 3sbio Revenue in Biopharmaceuticals Business (2016-2021)

11.12.5 3sbio Recent Development

11.13 Changchun High Tech

11.13.1 Changchun High Tech Company Details

11.13.2 Changchun High Tech Business Overview

11.13.3 Changchun High Tech Biopharmaceuticals Introduction

11.13.4 Changchun High Tech Revenue in Biopharmaceuticals Business (2016-2021)

11.13.5 Changchun High Tech Recent Development

11.14 CP Guojian

11.14.1 CP Guojian Company Details

11.14.2 CP Guojian Business Overview

11.14.3 CP Guojian Biopharmaceuticals Introduction

11.14.4 CP Guojian Revenue in Biopharmaceuticals Business (2016-2021)

11.14.5 CP Guojian Recent Development

11.15 Biotech

11.15.1 Biotech Company Details

11.15.2 Biotech Business Overview

11.15.3 Biotech Biopharmaceuticals Introduction

11.15.4 Biotech Revenue in Biopharmaceuticals Business (2016-2021)

11.15.5 Biotech Recent Development

11.16 Gelgen

11.16.1 Gelgen Company Details

11.16.2 Gelgen Business Overview

11.16.3 Gelgen Biopharmaceuticals Introduction

11.16.4 Gelgen Revenue in Biopharmaceuticals Business (2016-2021)

11.16.5 Gelgen Recent Development

11.17 Innovent

11.17.1 Innovent Company Details

11.17.2 Innovent Business Overview

11.17.3 Innovent Biopharmaceuticals Introduction

11.17.4 Innovent Revenue in Biopharmaceuticals Business (2016-2021)

11.17.5 Innovent Recent Development

11.18 Dong Bao

11.18.1 Dong Bao Company Details

11.18.2 Dong Bao Business Overview

11.18.3 Dong Bao Biopharmaceuticals Introduction

11.18.4 Dong Bao Revenue in Biopharmaceuticals Business (2016-2021)

11.18.5 Dong Bao Recent Development

11.19 Ganlee

11.19.1 Ganlee Company Details

11.19.2 Ganlee Business Overview

11.19.3 Ganlee Biopharmaceuticals Introduction

11.19.4 Ganlee Revenue in Biopharmaceuticals Business (2016-2021)

11.19.5 Ganlee Recent Development

11.20 United Laboratories

11.20.1 United Laboratories Company Details

11.20.2 United Laboratories Business Overview

11.20.3 United Laboratories Biopharmaceuticals Introduction

11.20.4 United Laboratories Revenue in Biopharmaceuticals Business (2016-2021)

11.20.5 United Laboratories Recent Development

11.21 SANDOZ (NOVARTIS)

11.21.1 SANDOZ (NOVARTIS) Company Details

11.21.2 SANDOZ (NOVARTIS) Business Overview

11.21.3 SANDOZ (NOVARTIS) Biopharmaceuticals Introduction

11.21.4 SANDOZ (NOVARTIS) Revenue in Biopharmaceuticals Business (2016-2021)

11.21.5 SANDOZ (NOVARTIS) Recent Development

11.22 Teva Pharmaceutical

11.22.1 Teva Pharmaceutical Company Details

11.22.2 Teva Pharmaceutical Business Overview

11.22.3 Teva Pharmaceutical Biopharmaceuticals Introduction

11.22.4 Teva Pharmaceutical Revenue in Biopharmaceuticals Business (2016-2021)

11.22.5 Teva Pharmaceutical Recent Development

11.23 Hospira （Pfizer）

11.23.1 Hospira （Pfizer） Company Details

11.23.2 Hospira （Pfizer） Business Overview

11.23.3 Hospira （Pfizer） Biopharmaceuticals Introduction

11.23.4 Hospira （Pfizer） Revenue in Biopharmaceuticals Business (2016-2021)

11.23.5 Hospira （Pfizer） Recent Development

11.24 MYLAN

11.24.1 MYLAN Company Details

11.24.2 MYLAN Business Overview

11.24.3 MYLAN Biopharmaceuticals Introduction

11.24.4 MYLAN Revenue in Biopharmaceuticals Business (2016-2021)

11.24.5 MYLAN Recent Development

11.25 Sun pharma

11.25.1 Sun pharma Company Details

11.25.2 Sun pharma Business Overview

11.25.3 Sun pharma Biopharmaceuticals Introduction

11.25.4 Sun pharma Revenue in Biopharmaceuticals Business (2016-2021)

11.25.5 Sun pharma Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

    Table 1. Global Biopharmaceuticals Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027

    Table 2. Key Players of Monoclonal Antibodies

    Table 3. Key Players of Interferon

    Table 4. Key Players of Colony-Stimulating Factor

    Table 5. Key Players of Erythropoietin

    Table 6. Key Players of Insulin

    Table 7. Key Players of Vaccines

    Table 8. Key Players of Growth Hormones

    Table 9. Key Players of Others

    Table 10. Global Biopharmaceuticals Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027

    Table 11. Global Biopharmaceuticals Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027

    Table 12. Global Biopharmaceuticals Market Size by Regions (2016-2021) & (US$ Million)

    Table 13. Global Biopharmaceuticals Market Share by Regions (2016-2021)

    Table 14. Global Biopharmaceuticals Forecasted Market Size by Regions (2022-2027) & (US$ Million)

    Table 15. Global Biopharmaceuticals Market Share by Regions (2022-2027)

    Table 16. Biopharmaceuticals Market Trends

    Table 17. Biopharmaceuticals Market Drivers

    Table 18. Biopharmaceuticals Market Challenges

    Table 19. Biopharmaceuticals Market Restraints

    Table 20. Global Biopharmaceuticals Revenue by Players (2016-2021) & (US$ Million)

    Table 21. Global Biopharmaceuticals Market Share by Players (2016-2021)

    Table 22. Global Top Biopharmaceuticals Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biopharmaceuticals as of 2020)

    Table 23. Ranking of Global Top Biopharmaceuticals Companies by Revenue (US$ Million) in 2020

    Table 24. Global 5 Largest Players Market Share by Biopharmaceuticals Revenue (CR5 and HHI) & (2016-2021)

    Table 25. Key Players Headquarters and Area Served

    Table 26. Key Players Biopharmaceuticals Product Solution and Service

    Table 27. Date of Enter into Biopharmaceuticals Market

    Table 28. Mergers & Acquisitions, Expansion Plans

    Table 29. Global Biopharmaceuticals Market Size by Type (2016-2021) (US$ Million)

    Table 30. Global Biopharmaceuticals Revenue Market Share by Type (2016-2021)

    Table 31. Global Biopharmaceuticals Forecasted Market Size by Type (2022-2027) (US$ Million)

    Table 32. Global Biopharmaceuticals Revenue Market Share by Type (2022-2027) & (US$ Million)

    Table 33. Global Biopharmaceuticals Market Size Share by Application (2016-2021) & (US$ Million)

    Table 34. Global Biopharmaceuticals Revenue Market Share by Application (2016-2021)

    Table 35. Global Biopharmaceuticals Forecasted Market Size by Application (2022-2027) (US$ Million)

    Table 36. Global Biopharmaceuticals Revenue Market Share by Application (2022-2027) & (US$ Million)

    Table 37. North America Biopharmaceuticals Market Size by Type (2016-2021) (US$ Million)

    Table 38. North America Biopharmaceuticals Market Size by Type (2022-2027) & (US$ Million)

    Table 39. North America Biopharmaceuticals Market Size by Application (2016-2021) (US$ Million)

    Table 40. North America Biopharmaceuticals Market Size by Application (2022-2027) & (US$ Million)

    Table 41. North America Biopharmaceuticals Market Size by Country (2016-2021) & (US$ Million)

    Table 42. North America Biopharmaceuticals Market Size by Country (2022-2027) & (US$ Million)

    Table 43. Europe Biopharmaceuticals Market Size by Type (2016-2021) (US$ Million)

    Table 44. Europe Biopharmaceuticals Market Size by Type (2022-2027) & (US$ Million)

    Table 45. Europe Biopharmaceuticals Market Size by Application (2016-2021) (US$ Million)

    Table 46. Europe Biopharmaceuticals Market Size by Application (2022-2027) & (US$ Million)

    Table 47. Europe Biopharmaceuticals Market Size by Country (2016-2021) & (US$ Million)

    Table 48. Europe Biopharmaceuticals Market Size by Country (2022-2027) & (US$ Million)

    Table 49. Asia-Pacific Biopharmaceuticals Market Size by Type (2016-2021) (US$ Million)

    Table 50. Asia-Pacific Biopharmaceuticals Market Size by Type (2022-2027) & (US$ Million)

    Table 51. Asia-Pacific Biopharmaceuticals Market Size by Application (2016-2021) (US$ Million)

    Table 52. Asia-Pacific Biopharmaceuticals Market Size by Application (2022-2027) & (US$ Million)

    Table 53. Asia-Pacific Biopharmaceuticals Market Size by Region (2016-2021) & (US$ Million)

    Table 54. Asia-Pacific Biopharmaceuticals Market Size by Region (2022-2027) & (US$ Million)

    Table 55. Latin America Biopharmaceuticals Market Size by Type (2016-2021) (US$ Million)

    Table 56. Latin America Biopharmaceuticals Market Size by Type (2022-2027) & (US$ Million)

    Table 57. Latin America Biopharmaceuticals Market Size by Application (2016-2021) (US$ Million)

    Table 58. Latin America Biopharmaceuticals Market Size by Application (2022-2027) & (US$ Million)

    Table 59. Latin America Biopharmaceuticals Market Size by Country (2016-2021) & (US$ Million)

    Table 60. Latin America Biopharmaceuticals Market Size by Country (2022-2027) & (US$ Million)

    Table 61. Middle East & Africa Biopharmaceuticals Market Size by Type (2016-2021) (US$ Million)

    Table 62. Middle East & Africa Biopharmaceuticals Market Size by Type (2022-2027) & (US$ Million)

    Table 63. Middle East & Africa Biopharmaceuticals Market Size by Application (2016-2021) (US$ Million)

    Table 64. Middle East & Africa Biopharmaceuticals Market Size by Application (2022-2027) & (US$ Million)

    Table 65. Middle East & Africa Biopharmaceuticals Market Size by Country (2016-2021) & (US$ Million)

    Table 66. Middle East & Africa Biopharmaceuticals Market Size by Country (2022-2027) & (US$ Million)

    Table 67. Roche Company Details

    Table 68. Roche Business Overview

    Table 69. Roche Biopharmaceuticals Product

    Table 70. Roche Revenue in Biopharmaceuticals Business (2016-2021) & (US$ Million)

    Table 71. Roche Recent Development

    Table 72. Amgen Company Details

    Table 73. Amgen Business Overview

    Table 74. Amgen Biopharmaceuticals Product

    Table 75. Amgen Revenue in Biopharmaceuticals Business (2016-2021) & (US$ Million)

    Table 76. Amgen Recent Development

    Table 77. AbbVie Company Details

    Table 78. AbbVie Business Overview

    Table 79. AbbVie Biopharmaceuticals Product

    Table 80. AbbVie Revenue in Biopharmaceuticals Business (2016-2021) & (US$ Million)

    Table 81. AbbVie Recent Development

    Table 82. Sanofi-Aventis Company Details

    Table 83. Sanofi-Aventis Business Overview

    Table 84. Sanofi-Aventis Biopharmaceuticals Product

    Table 85. Sanofi-Aventis Revenue in Biopharmaceuticals Business (2016-2021) & (US$ Million)

    Table 86. Sanofi-Aventis Recent Development

    Table 87. Johnson & Johnson Company Details

    Table 88. Johnson & Johnson Business Overview

    Table 89. Johnson & Johnson Biopharmaceuticals Product

    Table 90. Johnson & Johnson Revenue in Biopharmaceuticals Business (2016-2021) & (US$ Million)

    Table 91. Johnson & Johnson Recent Development

    Table 92. Pfizer Company Details

    Table 93. Pfizer Business Overview

    Table 94. Pfizer Biopharmaceuticals Product

    Table 95. Pfizer Revenue in Biopharmaceuticals Business (2016-2021) & (US$ Million)

    Table 96. Pfizer Recent Development

    Table 97. Novo Nordisk Company Details

    Table 98. Novo Nordisk Business Overview

    Table 99. Novo Nordisk Biopharmaceuticals Product

    Table 100. Novo Nordisk Revenue in Biopharmaceuticals Business (2016-2021) & (US$ Million)

    Table 101. Novo Nordisk Recent Development

    Table 102. Eli Lilly Company Details

    Table 103. Eli Lilly Business Overview

    Table 104. Eli Lilly Revenue in Biopharmaceuticals Business (2016-2021) & (US$ Million)

    Table 105. Eli Lilly Recent Development

    Table 106. Novartis Company Details

    Table 107. Novartis Business Overview

    Table 108. Novartis Biopharmaceuticals Product

    Table 109. Novartis Revenue in Biopharmaceuticals Business (2016-2021) & (US$ Million)

    Table 110. Novartis Recent Development

    Table 111. Merck Company Details

    Table 112. Merck Business Overview

    Table 113. Merck Biopharmaceuticals Product

    Table 114. Merck Revenue in Biopharmaceuticals Business (2016-2021) & (US$ Million)

    Table 115. Merck Recent Development

    Table 116. Sun Company Details

    Table 117. Sun Business Overview

    Table 118. Sun Biopharmaceuticals Product

    Table 119. Sun Revenue in Biopharmaceuticals Business (2016-2021) & (US$ Million)

    Table 120. Sun Recent Development

    Table 121. 3sbio Company Details

    Table 122. 3sbio Business Overview

    Table 123. 3sbio Biopharmaceuticals Product

    Table 124. 3sbio Revenue in Biopharmaceuticals Business (2016-2021) & (US$ Million)

    Table 125. 3sbio Recent Development

    Table 126. Changchun High Tech Company Details

    Table 127. Changchun High Tech Business Overview

    Table 128. Changchun High Tech Biopharmaceuticals Product

    Table 129. Changchun High Tech Revenue in Biopharmaceuticals Business (2016-2021) & (US$ Million)

    Table 130. Changchun High Tech Recent Development

    Table 131. CP Guojian Company Details

    Table 132. CP Guojian Business Overview

    Table 133. CP Guojian Biopharmaceuticals Product

    Table 134. CP Guojian Revenue in Biopharmaceuticals Business (2016-2021) & (US$ Million)

    Table 135. CP Guojian Recent Development

    Table 136. Biotech Company Details

    Table 137. Biotech Business Overview

    Table 138. Biotech Biopharmaceuticals Product

    Table 139. Biotech Revenue in Biopharmaceuticals Business (2016-2021) & (US$ Million)

    Table 140. Biotech Recent Development

    Table 141. Gelgen Company Details

    Table 142. Gelgen Business Overview

    Table 143. Gelgen Biopharmaceuticals Product

    Table 144. Gelgen Revenue in Biopharmaceuticals Business (2016-2021) & (US$ Million)

    Table 145. Gelgen Recent Development

    Table 146. Innovent Company Details

    Table 147. Innovent Business Overview

    Table 148. Innovent Biopharmaceuticals Product

    Table 149. Innovent Revenue in Biopharmaceuticals Business (2016-2021) & (US$ Million)

    Table 150. Innovent Recent Development

    Table 151. Dong Bao Company Details

    Table 152. Dong Bao Business Overview

    Table 153. Dong Bao Biopharmaceuticals Product

    Table 154. Dong Bao Revenue in Biopharmaceuticals Business (2016-2021) & (US$ Million)

    Table 155. Dong Bao Recent Development

    Table 156. Ganlee Company Details

    Table 157. Ganlee Business Overview

    Table 158. Ganlee Biopharmaceuticals Product

    Table 159. Ganlee Revenue in Biopharmaceuticals Business (2016-2021) & (US$ Million)

    Table 160. Ganlee Recent Development

    Table 161. United Laboratories Company Details

    Table 162. United Laboratories Business Overview

    Table 163. United Laboratories Biopharmaceuticals Product

    Table 164. United Laboratories Revenue in Biopharmaceuticals Business (2016-2021) & (US$ Million)

    Table 165. United Laboratories Recent Development

    Table 166. SANDOZ (NOVARTIS) Company Details

    Table 167. SANDOZ (NOVARTIS) Business Overview

    Table 168. SANDOZ (NOVARTIS) Biopharmaceuticals Product

    Table 169. SANDOZ (NOVARTIS) Revenue in Biopharmaceuticals Business (2016-2021) & (US$ Million)

    Table 170. SANDOZ (NOVARTIS) Recent Development

    Table 171. Teva Pharmaceutical Company Details

    Table 172. Teva Pharmaceutical Business Overview

    Table 173. Teva Pharmaceutical Biopharmaceuticals Product

    Table 174. Teva Pharmaceutical Revenue in Biopharmaceuticals Business (2016-2021) & (US$ Million)

    Table 175. Teva Pharmaceutical Recent Development

    Table 176. Hospira （Pfizer） Company Details

    Table 177. Hospira （Pfizer） Business Overview

    Table 178. Hospira （Pfizer） Biopharmaceuticals Product

    Table 179. Hospira （Pfizer） Revenue in Biopharmaceuticals Business (2016-2021) & (US$ Million)

    Table 180. Hospira （Pfizer） Recent Development

    Table 181. MYLAN Company Details

    Table 182. MYLAN Business Overview

    Table 183. MYLAN BiopharmaceuticalsProduct

    Table 184. MYLAN Revenue in Biopharmaceuticals Business (2016-2021) & (US$ Million)

    Table 185. MYLAN Recent Development

    Table 186. Sun pharma Company Details

    Table 187. Sun pharma Business Overview

    Table 188. Sun pharma Biopharmaceuticals Product

    Table 189. Sun pharma Revenue in Biopharmaceuticals Business (2016-2021) & (US$ Million)

    Table 190. Sun pharma Recent Development

    Table 191. Research Programs/Design for This Report

    Table 192. Key Data Information from Secondary Sources

    Table 193. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Biopharmaceuticals Market Share by Type: 2020 VS 2027

    Figure 2. Monoclonal Antibodies Features

    Figure 3. Interferon Features

    Figure 4. Colony-Stimulating Factor Features

    Figure 5. Erythropoietin Features

    Figure 6. Insulin Features

    Figure 7. Vaccines Features

    Figure 8. Growth Hormones Features

    Figure 9. Others Features

    Figure 10. Global Biopharmaceuticals Market Share by Application: 2020 VS 2027

    Figure 11. Tumor Case Studies

    Figure 12. Diabetes Case Studies

    Figure 13. Cardiovascular Case Studies

    Figure 14. Hemophilia Case Studies

    Figure 15. Others Case Studies

    Figure 16. Biopharmaceuticals Report Years Considered

    Figure 17. Global Biopharmaceuticals Market Size (US$ Million), Year-over-Year: 2016-2027

    Figure 18. Global Biopharmaceuticals Market Size (US$ Million), 2016 VS 2021 VS 2027

    Figure 19. Global Biopharmaceuticals Market Share by Regions: 2020 VS 2027

    Figure 20. Global Biopharmaceuticals Market Share by Regions (2022-2027)

    Figure 21. Global Biopharmaceuticals Market Share by Players in 2020

    Figure 22. Global Top Biopharmaceuticals Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biopharmaceuticals as of 2020

    Figure 23. The Top 10 and 5 Players Market Share by Biopharmaceuticals Revenue in 2020

    Figure 24. Global Biopharmaceuticals Revenue Market Share by Type (2016-2021)

    Figure 25. Global Biopharmaceuticals Revenue Market Share by Type (2022-2027)

    Figure 26. North America Biopharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 27. North America Biopharmaceuticals Market Share by Type (2016-2027)

    Figure 28. North America Biopharmaceuticals Market Share by Application (2016-2027)

    Figure 29. North America Biopharmaceuticals Market Share by Country (2016-2027)

    Figure 30. United States Biopharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 31. Canada Biopharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 32. Europe Biopharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 33. Europe Biopharmaceuticals Market Share by Type (2016-2027)

    Figure 34. Europe Biopharmaceuticals Market Share by Application (2016-2027)

    Figure 35. Europe Biopharmaceuticals Market Share by Country (2016-2027)

    Figure 36. Germany Biopharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 37. France Biopharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 38. U.K. Biopharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 39. Italy Biopharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 40. Russia Biopharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 41. Nordic Biopharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 42. Asia-Pacific Biopharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 43. Asia-Pacific Biopharmaceuticals Market Share by Type (2016-2027)

    Figure 44. Asia-Pacific Biopharmaceuticals Market Share by Application (2016-2027)

    Figure 45. Asia-Pacific Biopharmaceuticals Market Share by Region (2016-2027)

    Figure 46. China Biopharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 47. Japan Biopharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 48. South Korea Biopharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 49. Southeast Asia Biopharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 50. India Biopharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 51. Australia Biopharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 52. Latin America Biopharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 53. Latin America Biopharmaceuticals Market Share by Type (2016-2027)

    Figure 54. Latin America Biopharmaceuticals Market Share by Application (2016-2027)

    Figure 55. Latin America Biopharmaceuticals Market Share by Country (2016-2027)

    Figure 56. Mexico Biopharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 57. Brazil Biopharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 58. Middle East & Africa Biopharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 59. Middle East & Africa Biopharmaceuticals Market Share by Type (2016-2027)

    Figure 60. Middle East & Africa Biopharmaceuticals Market Share by Application (2016-2027)

    Figure 61. Middle East & Africa Biopharmaceuticals Market Share by Country (2016-2027)

    Figure 62. Turkey Biopharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 63. Saudi Arabia Biopharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 64. UAE Biopharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 65. Roche Revenue Growth Rate in Biopharmaceuticals Business (2016-2021)

    Figure 66. Amgen Revenue Growth Rate in Biopharmaceuticals Business (2016-2021)

    Figure 67. AbbVie Revenue Growth Rate in Biopharmaceuticals Business (2016-2021)

    Figure 68. Sanofi-Aventis Revenue Growth Rate in Biopharmaceuticals Business (2016-2021)

    Figure 69. Johnson & Johnson Revenue Growth Rate in Biopharmaceuticals Business (2016-2021)

    Figure 70. Pfizer Revenue Growth Rate in Biopharmaceuticals Business (2016-2021)

    Figure 71. Novo Nordisk Revenue Growth Rate in Biopharmaceuticals Business (2016-2021)

    Figure 72. Eli Lilly Revenue Growth Rate in Biopharmaceuticals Business (2016-2021)

    Figure 73. Novartis Revenue Growth Rate in Biopharmaceuticals Business (2016-2021)

    Figure 74. Merck Revenue Growth Rate in Biopharmaceuticals Business (2016-2021)

    Figure 75. Sun Revenue Growth Rate in Biopharmaceuticals Business (2016-2021)

    Figure 76. 3sbio Revenue Growth Rate in Biopharmaceuticals Business (2016-2021)

    Figure 77. Changchun High Tech Revenue Growth Rate in Biopharmaceuticals Business (2016-2021)

    Figure 78. CP Guojian Revenue Growth Rate in Biopharmaceuticals Business (2016-2021)

    Figure 79. Biotech Revenue Growth Rate in Biopharmaceuticals Business (2016-2021)

    Figure 80. Gelgen Revenue Growth Rate in Biopharmaceuticals Business (2016-2021)

    Figure 81. Innovent Revenue Growth Rate in Biopharmaceuticals Business (2016-2021)

    Figure 82. Dong Bao Revenue Growth Rate in Biopharmaceuticals Business (2016-2021)

    Figure 83. Ganlee Revenue Growth Rate in Biopharmaceuticals Business (2016-2021)

    Figure 84. United Laboratories Revenue Growth Rate in Biopharmaceuticals Business (2016-2021)

    Figure 85. SANDOZ (NOVARTIS) Revenue Growth Rate in Biopharmaceuticals Business (2016-2021)

    Figure 86. Teva Pharmaceutical Revenue Growth Rate in Biopharmaceuticals Business (2016-2021)

    Figure 87. Hospira （Pfizer） Revenue Growth Rate in Biopharmaceuticals Business (2016-2021)

    Figure 88. MYLAN Revenue Growth Rate in Biopharmaceuticals Business (2016-2021)

    Figure 89. Sun pharma Revenue Growth Rate in Biopharmaceuticals Business (2016-2021)

    Figure 90. Bottom-up and Top-down Approaches for This Report

    Figure 91. Data Triangulation

    Figure 92. Key Executives Interviewed